CARDIOTECH INTERNATIONAL INC
8-A12B, 1996-05-20
PHARMACEUTICAL PREPARATIONS
Previous: STRUCTURED ASSET SECURITIES CORP SERIES 1995-4, 8-K, 1996-05-20
Next: CERION TECHNOLOGIES INC, 8-A12G, 1996-05-20



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                      -----------------------------------

                                    FORM 8-A

                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                     PURSUANT TO SECTION 12(b) OR (g) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                         CARDIOTECH INTERNATIONAL, INC.
             ------------------------------------------------------  
             (Exact name of registrant as specified in its charter)


             MASSACHUSETTS                                 04-3186647
- ----------------------------------------       ---------------------------------
(State of incorporation or organization)       (IRS Employer Identification No.)

      11 STATE STREET, WOBURN, MASSACHUSETTS                     01801
- --------------------------------------------------------------------------------
     (Address of principal executive offices)                  (Zip Code)


Securities to be registered pursuant to Section 12(b) of the Act:

                     COMMON STOCK, $.01 PAR VALUE PER SHARE
                     --------------------------------------
                                (Title of Class)

Name of exchange on which securities are to be registered: American Stock
Exchange

Securities to be registered pursuant to Section 12(g) of the Act:

                                      NONE

                            Total Number of Pages: 3


<PAGE>   2




Item 1.  Description of Securities To Be Registered.
         ------------------------------------------

     The Registrant incorporates herein by reference the following portions of
the Registrant's Registration Statement on Form 10 filed under the Securities
Exchange Act of 1934, as amended, on March 20, 1996, as the same may be
subsequently amended:

         Description of Capital Stock
                --   Common Stock
                --   Preferred Stock
                --   Massachusetts Law and Certain Charter and By-Law Provisions
                --   Dividends
                --   Transfer Agent and Registrar

                                       -2-


<PAGE>   3


                                    SIGNATURE

     Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.

                                    CARDIOTECH INTERNATIONAL, INC.

                                    By: /s/ Michael Szycher
                                        --------------------------------------
                                         Michael Szycher
                                         Chairman, Chief Executive Officer and
                                         Treasurer

Dated:  May 20, 1996

                                       -3-




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission